Zacks.com on MSN1h
Catalent Stock Flat Following the Sell Agreement With Ardena
CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
FiercePharma2d
Catalent offloads New Jersey manufacturing plant, HQ to Belgian CDMO Ardena
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...
STAT6d
Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants
U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading ...
ETF Daily News25d
Catalent, Inc. (NYSE:CTLT) Shares Acquired by XTX Topco Ltd
Catalent, Inc. has a 12 month low of $31.80 and a 12 month high of $61.20. The company has a market cap of $10.86 billion, a price-to-earnings ratio of -9.84, a PEG ratio of 1.88 and a beta of 1. ...
Business Insider22d
Hold Rating on Catalent Amid Deal Uncertainties and Conservative Financial Outlook
Robert W. Baird analyst Eric Coldwell downgraded the rating on Catalent (CTLT – Research Report) to a Hold today, setting a price target of $63.50. Eric Coldwell has given his Hold rating due to ...